Skip to main content
Livermore
Livermore
ZHEN

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

GSK holding history

GSK plc in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
4,548
Value
$238.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,548$238.4K<0.1%+1,045+29.8%AddedHolders
Q1 20263,503$193.3K<0.1%−81−2.3%ReducedHolders
Q4 20253,584$175.7K<0.1%+721+25.2%AddedHolders
Q3 20252,863$123.6K<0.1%−64−2.2%ReducedHolders
Q2 20252,927$112.4K<0.1%−150−4.9%ReducedHolders
Q1 20253,077$119.2K<0.1%+436+16.5%AddedHolders
Q4 20242,641$89.3K<0.1%+42+1.6%AddedHolders
Q3 20242,599$106.2K<0.1%−10−0.4%ReducedHolders
Q2 20242,609$100.5K<0.1%+1,022+64.4%AddedHolders
Q1 20241,587$68.0K<0.1%+81+5.4%AddedHolders
Q4 20231,506$55.8K<0.1%+1+0.1%AddedHolders
Q3 20231,505$54.6K<0.1%+1+0.1%AddedHolders
Q2 20231,504$53.6K<0.1%+1+0.1%AddedHolders
Q1 20231,503$53.5K<0.1%+65+4.5%AddedHolders
Q4 20221,438$50.5K<0.1%+43+3.1%AddedHolders
Q3 20221,395$41.1K<0.1%−647−31.7%ReducedHolders
Q2 20222,042$88.9K<0.1%−11−0.5%ReducedHolders
Q1 20222,053$89.4K<0.1%+10.0%AddedHolders
Q4 20212,052$90.5K<0.1%−110−5.1%ReducedHolders
Q3 20212,162$82.6K<0.1%+2+0.1%AddedHolders
Q2 20212,160$86.0K<0.1%+2+0.1%AddedHolders
Q1 20212,158$77.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.